Vimab Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Peter Fredell

Chief executive officer

SEK 2.0m

Total compensation

CEO salary percentagen/a
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenure2.9yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story

Nov 06
Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story

We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Mar 14
We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

CEO

Peter Fredell (59 yo)

4.9yrs

Tenure

SEK 2,000,000

Compensation

Mr. Peter Fredell serves as Chief Executive Officer at Vimab Group AB (publ) (formerly known as Headsent AB (publ)) since 2020 and also serves as its Director since 2022. He served as the Chief Executive O...


Leadership Team

NamePositionTenureCompensationOwnership
Peter Fredell
CEO & Director4.9yrsSEK 2.00mno data
Anna Bonde
Chief Financial Officer3.9yrsno data0.42%
SEK 910.0k
Markus Anglered
Deputy CEO & COO2.9yrsno data8.65%
SEK 18.8m
Rickard Nyberg
Sales & Technical Manager1.9yrsno data0.0068%
SEK 14.7k
Jockum Nilsson
C. I. Oless than a yearno data0.031%
SEK 67.8k

2.9yrs

Average Tenure

48yo

Average Age

Experienced Management: VIMAB's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Fredell
CEO & Director2.9yrsSEK 2.00mno data
Michael Sundin
Directorless than a yearno datano data
Joakim Hörwing
Director13.9yrsSEK 100.00k0.78%
SEK 1.7m
Gunnar Jardelöv
Independent Chairman of the Board2.9yrsSEK 175.00kno data
Hanna Myhrman
Independent Director2.9yrsSEK 100.00kno data
Edvin Quinlan
Employee Representative Directorless than a yearno datano data

2.9yrs

Average Tenure

59yo

Average Age

Experienced Board: VIMAB's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 05:14
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vimab Group AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution